Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Vertika Gautam is active.

Publication


Featured researches published by Vertika Gautam.


Medicinal Chemistry Research | 2011

3D-QSAR studies of 4-quinolone derivatives as high-affinity ligands at the benzodiazepine site of brain GABAA receptors

Anand Gaurav; Mange Ram Yadav; Rajani Giridhar; Vertika Gautam; Ranjit Singh

Three dimensional quantitative structure activity relationship approach using CoMFA and CoMSIA was applied to a series of 4-quinolone derivatives as high-affinity ligands at the benzodiazepine site of brain GABAA receptors. For the purpose, 27 compounds were used to develop models. 3D-QSAR models with high-squared correlation coefficient of up to 0.979 for CoMFA and 0.931 for CoMSIA were established. The robustness of the model was confirmed with the help of leave one out cross-validation method with rcv2 values of up to 0.526 and 0.546 for CoMFA and CoMSIA, respectively. Developed models highlighted the importance of shape of the molecules, i.e., steric descriptors for GABAA receptor binding.


Journal of Receptor, Ligand and Channel Research | 2014

Structure-based three-dimensional pharmacophores as an alternative to traditional methodologies

Anand Gaurav; Vertika Gautam

Structure-based pharmacophore approaches have become widely used in drug discovery and design. This can be attributed to the development of new tools and methods over the past decade. Various tools based on different premises have been developed, including active site information in traditional pharmacophores. These tools have been widely used in virtual screening, de novo design, and lead optimization and been proven to be highly successful. Studies based on simultaneous use of structure-based pharmacophores, ligand-based phar- macophores, and docking have also come into the picture recently. Here, the development of structure-based pharmacophores as an alternative to traditional drug discovery approaches is discussed, with emphasis on the advances and latest developments in tools and success stories


Medicinal Chemistry | 2009

QSAR Studies on 4-Quinolone Derivatives as High-Affinity Ligands at the Benzodiazepine Site of Brain GABAA Receptors

Anand Gaurav; Mange Ram Yadav; Rajani Giridhar; Vertika Gautam; Ranjit Singh

Quantitative structure activity relationship approach using stepwise regression analysis was applied to a series of 4-quinolone derivatives as high-affinity ligands at the benzodiazepine site of brain GABA(A) receptors. For the purpose 25 compounds were used to develop models. Statistically significant equations were obtained with high squared correlation coefficient (r(2)=0.8761, 0.9295 and 0.8705) and low root mean square error (RMSE=0.4844, 0.3894 and 0.4952). The robustness of the model was confirmed with the help of leave one out cross validation method which exhibited high r(2)(cv) values (r(2)(cv)=0.7875, 0.8263 and 0.7927). A good correlation of various molecular shape parameters, like ovality, Szeged index, and energy of the molecule with the GABA(A) affinity was achieved.


Archive | 2010

DEVELOPMENT AND VALIDATION OF A RP-HPLC METHOD FOR THE DETERMINATION OF CHLORPHENIRAMINE MALEATE AND PHENYLEPHRINE IN PHARMACEUTICAL DOSAGE FORM

Mukesh Maithani; Richa Raturi; Vertika Gautam; Amrendra Kumar Chaudhary; Anand Gaurav; Ranjit Singh


Archive | 2010

SIMULTANEOUS ESTIMATION OF AMBROXOL HYDROCHLORIDE AND CETIRIZINE HYDROCHLORIDE IN TABLET DOSAGE FORM BY RP-HPLC METHOD

Mukesh Maithani; Richa Raturi; Vertika Gautam; Anand Gaurav; Ranjit Singh


Medicinal Chemistry Research | 2012

Quantitative structure–activity relationship and design of polysubstituted quinoline derivatives as inhibitors of phosphodiesterase 4

Anand Gaurav; Vertika Gautam; Ranjit Singh


Letters in Drug Design & Discovery | 2011

Exploring the Structure Activity Relationships of Imidazole Containing Tetrahydrobenzodiazepines as Farnesyltransferase Inhibitors: A QSAR Study

Anand Gaurav; Vertika Gautam; Ranjit Singh


Journal of Chinese Pharmaceutical Sciences | 2017

Syntheses, characterization, and evaluation of novel non-carboxylic analogues of Gemfibrozil: a bioisosteric approach

Nidhi Kala; Anand Gaurav; Vertika Gautam


Iranian Journal of Pharmaceutical Research | 2017

Pharmacophore Based Virtual Screening Approach to Identify Selective PDE4B Inhibitors

Anand Gaurav; Vertika Gautam


3rd International Conference on Computation for Science and Technology (ICCST-3) | 2015

Computational Alanine Scanning Mutagenesis: Characterizing the hotspots of ILK-Ankyrin Repeat and PINCH1 Complex

Vertika Gautam; Nadia Hanim Sabri; Wei Lim Chong; Sharifuddin M. Zain; Noorsaadah Abd. Rahman; Vannajan Sanghiran Lee; Anand Gaurav

Collaboration


Dive into the Vertika Gautam's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Mange Ram Yadav

Maharaja Sayajirao University of Baroda

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Rajani Giridhar

Maharaja Sayajirao University of Baroda

View shared research outputs
Top Co-Authors

Avatar

Richa Raturi

Baba Farid University of Health Sciences

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge